Showing results (351-360 of 375) with videos related to
Sort By:
Pageof 38
Frontiers in Public Health|December 18, 2023
Using the exploration, preparation, implementation, sustainment (EPIS) framework to assess the cooperative re-engagement controlled trial (CoRECT)Heather Elder, Simona G Lang, Merceditas Villanueva, et al.Lupus|March 25, 2022
Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: A possible mechanism for the reversal of atherosclerosis in the diseaseMaria G Lang, Carmen Gc Vinagre, Eloisa Bonfa, et al.The British Journal of Dermatology|June 21, 2008
Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitroA Pollreisz, A Assinger, S Hacker, et al.American Journal of Preventive Medicine|January 18, 2011
Using the Clinical Prevention and Population Health Curriculum Framework to encourage curricular changeRika Maeshiro, Clyde H Evans, Joan M Stanley, et al.BMC Genomics|December 1, 2018
The impact of genome evolution on the allotetraploid Nicotiana rustica - an intriguing story of enhanced alkaloid productionN Sierro, J N D Battey, L Bovet, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2007
Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's diseaseBarbara Leinweber, J Carsten Möller, Andre Scherag, et al.Brain Research. Molecular Brain Research|September 23, 2003
Seven cDNAs enriched following hippocampal lesion: possible roles in neuronal responses to injuryMitch Price, Molly G Lang, Ami T Frank, et al.Annales De Pathologie|July 27, 2001
[Activity and cost analysis in surgical pathology. Experience of a French university laboratory using the activity-based costing method]J P Bellocq, N Biron, S Kessler, et al.Genome Biology|July 31, 2013
A blood based 12-miRNA signature of Alzheimer disease patientsPetra Leidinger, Christina Backes, Stephanie Deutscher, et al.British Journal of Pharmacology|July 1, 2008
Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig modelX Yao, D L Anderson, S A Ross, et al.Pageof 38